Pharmacologic management of urinary incontinence in women

被引:7
作者
Wein, AJ
Rovner, ES
机构
[1] Hosp Univ Penn, Div Urol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn Hlth Syst, Continence & Pelv Hlth Ctr, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/S0094-0143(02)00053-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This article summarizes current thought regarding the efficacy of various types of drug therapy for incontinence in women, borrowing liberally from similar previous presentations. Space limitations for this chapter necessitate some simplification and condensation of these subjects. References have generally been chosen because of their informational or review content and not because of originality or initial publication on a particular subject.
引用
收藏
页码:537 / +
页数:15
相关论文
共 86 条
[1]  
ABRAMOWICZ M, 2000, MED LETT DRUGS THER, V42, P113
[2]  
*AG HLTH CAR POL R, 1992, AHCPR PUBL
[3]  
ANDERSON KE, 1993, PHARMACOL REV, V45, P253
[4]   The concept of uroselectivity [J].
Andersson, KE .
EUROPEAN UROLOGY, 1998, 33 :7-11
[5]   Advances in the pharmacological control of the bladder [J].
Andersson, KE .
EXPERIMENTAL PHYSIOLOGY, 1999, 84 (01) :195-213
[6]  
Andersson KE, 1999, INCONTINENCE, P447
[7]   CURRENT CONCEPTS IN THE TREATMENT OF DISORDERS OF MICTURITION [J].
ANDERSSON, KE .
DRUGS, 1988, 35 (04) :477-494
[8]  
Andersson KE, 1999, ADV EXP MED BIOL, V462, P241
[9]   Changes in bladder tone during filling: Pharmacological aspects [J].
Andersson, KE .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1999, 33 :67-72
[10]   Treatment of overactive bladder: Other drug mechanisms [J].
Andersson, KE .
UROLOGY, 2000, 55 (5A) :51-57